Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Nutrition & Dietetics Volume 4 (2018), Article ID 4:IJCND-128, 11 pages
https://doi.org/10.15344/2456-8171/2018/128
Original Article
Dyslipidemia and Other Risk Factors Among Egyptian Patients with Type-2 Diabetes Mellitus and the Impact of Dietary Intervention with Thermally Treated Tomato Juice

Laila Hussein1*, Sancia Gaetani2, Sabila G Mousa3, Laura D'Evoli2 and Nahed Hussein4

1National Research Center, Department of Nutrition, Giza, Egypt
2National Research Institute on Food and Nutrition, Rome, Italy
3Faculty of Medicine, Dept Internal Medicine, El Azhar Univ., Cairo, Egypt
4Faculty of Special Education, Dept nutrition, Ain Shams Univ, Cairo, Egypt
Dr. Laila Hussein, National Research Center, Department of Nutrition, Giza, Egypt; E-mail: dr.lailahussein@yahoo.com
11 January 2018; 17 February 2018; 19 February 2018
Hussein L, Gaetani S, Mousa SG, D'Evoli L, Hussein N (2018) Dyslipidemia and Other Risk Factors Among Egyptian Patients with Type-2 Diabetes Mellitus and the Impact of Dietary Intervention with Thermally Treated Tomato Juice. Int J Clin Nutr Diet 4: 127. doi: https://doi.org/10.15344/2456-8171/2018/127
© 2018 Hussein et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. WHO (2016) Global report on diabetes. Diabetes Mellitus – epidemiology, prevention and control. WHO, Geneva, Switzerland
  2. Shu L, Shen XM, Li C, Zhang XY, Zheng PF, et al. (2017) Dietary patterns are associated with type 2 diabetes mellitus among middle-aged adults in Zhejiang Province, China. Nutr J 16: 81 [CrossRef] [Google Scholar] [PubMed]
  3. McCulloch DK, Munshi M, Nathan DM, Schmader KE, Mulder JE, et al. (2017) Treatment of type 2 diabetes mellitus in the older patient.UpTodate [View]
  4. Franz MJ, Boucher JL, Rutten-Ramos S, VanWormer JJ (2015) Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet 115: 1447-1463 [CrossRef] [Google Scholar] [PubMed]
  5. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, et al. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345: 790-797 [CrossRef] [Google Scholar]
  6. Nowotny K, Jung T, Hӧhn A, Weber D, GruneT, et al. (2015) Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5: 194-222 [CrossRef] [Google Scholar] [PubMed]
  7. Wada R, Yagihashi S (2005) Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann N Y Acad Sci 1043: 598-604 [CrossRef] [Google Scholar] [PubMed]
  8. Vistoli G, De Maddis D, Cipak A, Zarkovic N, Carini M et al. (2013) Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radical Research 47: 3-27 [CrossRef] [Google Scholar] [PubMed]
  9. Bray GA, Nielsen SJ, Popkin BM (2004) Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J ClinNutr 79: 537-543 [CrossRef] [Google Scholar] [PubMed]
  10. Horst K W, Schene MR, Holman R, Romijn JA, Serlie MJ, et al. (2016) Effect of fructose consumption on insulin sensitivity in nondiabetic subjects: a systematic review and meta-analysis of diet-intervention trials. AJCN 104: 1562-1576 [CrossRef] [Google Scholar] [PubMed]
  11. Turk Z, Mesić R, Benko B (1998) Comparison of advanced glycation end products on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control. ClinChimActa 277: 159-170 [CrossRef] [Google Scholar] [PubMed]
  12. Cerf ME (2013) Beta cell dysfunction and insulin resistance. Front Endocrinol 4: 37 [CrossRef] [Google Scholar] [PubMed]
  13. Kalyani RR, MD, Egan JM (2013) Diabetes and altered glucose metabolism with aging. MetabClinEndocrinol 42: 33-347 [CrossRef] [Google Scholar] [PubMed]
  14. Montonen J, Knekt P, Jarvinen R (2004) Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27: 362-366 [CrossRef] [Google Scholar] [PubMed]
  15. Wu W, Brickman AM, Luchsinger J, Ferrazzano P, Pichiule P, et al. (2008) The brain in the age of old: Hippocampal formation is targeted differentially by diseases of late life. Ann Neurol 64: 698-706 [CrossRef] [Google Scholar] [PubMed]
  16. Hanssen KF (1997) Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes 46: S101-S103 [CrossRef] [Google Scholar] [PubMed]
  17. Kitabchi AE (1977) Proinsulin and C-peptide: a review. Metabolism 26: 547- 587 [CrossRef] [Google Scholar] [PubMed]
  18. Leighton E, Sainsbury CAR, Jones GC (2017) A practical review of C-peptide testing in diabetes. Diabetes Ther 8: 475-487 [CrossRef] [Google Scholar] [PubMed]
  19. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T, et al. (2007) Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J ClinEndocrinol Metabolism 92: 2712-2719 [CrossRef] [Google Scholar] [PubMed]
  20. Shi J, Le MaguerM (2000) Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit Rev Biotechnol 20: 293-334 [CrossRef] [Google Scholar] [PubMed]
  21. Lazarus SA, Bowen K, Garg ML (2004) Tomato juice and platelet aggregation in Type 2 Diabetes. JAMA; 292: 805-806 [CrossRef] [Google Scholar] [PubMed]
  22. Khachik F, Goli MB, Beecher GR, Holden J, Lusby WR, et al. (1992) Effect of food preparation on qualitative and quantitative distribution of major carotenoid constituents of tomatoes and several green vegetables. JAgric Food Chem 40: 390-398 [CrossRef] [Google Scholar]
  23. Brazionis L, Rowley K, Itsiopoulos C, O'DeaK (2009) Plasma carotenoids and diabetic retinopathy. Br J Nutr 101: 270-277 [CrossRef] [Google Scholar] [PubMed]
  24. Kiho T, Usui S, Hirano K, Aizawa K, Inakuma T, et al. (2004) Tomato paste fraction inhibiting the formation of advanced glycation end products. BioscBiotechnolBiochem 68: 200-205 [CrossRef] [Google Scholar] [PubMed]
  25. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, without Use of the Preparative Ultracentrifuge. Clinical Chemistry 18: 499-502 [Google Scholar] [PubMed]
  26. Craft NE, Brown ED, Smith C (1988) Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. ClinChem 34: 44-48 [Google Scholar] [PubMed]
  27. Britton G (1995) Absorption coefficients of common carotenes. In:"Britton G, Liaen-Jensen S, Pfander H. Editors "Carotenoids spectroscopy". 18; pp13-63.BirkhauserVerlag
  28. De LeenheerAP, De RevereVO, De RuyterMG, Claeys AE (1979) Simultaneous determination of retinol and a-tocopherol in human serum by high-performance liquid chromatography. J. Chromatogr 162: 408-413 [CrossRef] [Google Scholar] [PubMed]
  29. Hussein L, Ali M (2000) Cord plasma retinol level and its impact on birth weight and growth velocity in infancy. Nutr Res 20: 1361-1366 [CrossRef] [Google Scholar]
  30. Khachik F, Carvalho L, Bernstein PS, Muir GJ, Zhao DY, et al. (2002) Chemistry, distribution, and metabolism oftomato carotenoids and their impact on human health. ExpBiol Med 227: 845-851 [CrossRef] [Google Scholar] [PubMed]
  31. WHO IDF consultation report (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva, Switzerland [Google Scholar]
  32. Klein BEK, Klein R, Lee KE (2002) Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes care 25: 1790-1794 [CrossRef] [Google Scholar] [PubMed]
  33. Jones AG, Hattersley AT (2013) The clinical utility of C-peptide measurement in the care of patients with diabetes. DiabetMed 30: 803-817 [CrossRef] [Google Scholar] [PubMed]
  34. Steffes MW, Sibley S, Jackson M, Thomas W (2003) Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 26: 832-836 [CrossRef] [Google Scholar] [PubMed]
  35. Chentli F, Azzoug S, Mahgoun S (2015) Diabetes mellitus in elderly. Indian J Endocrinol Metab. 19: 744-752 [CrossRef] [PubMed]
  36. Li S, Guo S, He F, Zhang M, He J, et al. (2015) Prevalence of diabetes mellitus and impaired fasting glucose, associated with risk factors in rural Kazakh adults in Xinjiang, China. Int J Environ Res Public Health 12: 554- 565 [CrossRef] [Google Scholar] [PubMed]
  37. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D, et al. (2012) Metabolic syndrome and risk of cancer. Diabetic care 35: 2402-2411 [CrossRef] [PubMed]
  38. Arsenault BJ, Rana JS, Stroes ESG, Després JP, Shah PK et al. (2009) Beyond low-density lipoprotein cholesterol: Respective contributions of non–high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am College Cardiol; 55: 35-41 [CrossRef] [Google Scholar] [PubMed]
  39. Chen Y, Liu L, GuL, Babineaux S, Colclough H, et al. (2015) Glycemic control in Chinese patients with type 2 diabetes mellitus receiving oral antihyperglycemic medication-only or insulin-only treatment: A crosssectional survey. Diabetes Ther 6: 197-211 [CrossRef] [Google Scholar] [PubMed]
  40. BA JK, Delafield R, Davis J, Mau MK (2013) Characteristics of patients with Type 2 diabetes mellitus in two rural, medically underserved communities. Hawai‘I. J Medicine Public Health 72: 191-196 [Google Scholar] [PubMed]
  41. Mohamed E, Mohamed M, Rashid FA (2004) Dyslipidemia pattern of patients with type 2 diabetes mellitus. Malaysian J Med Sci 11: 44-51 [PubMed]
  42. WHO Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO (1999) World Health Organization. World Health Organization - Geneva – Switzerland
  43. American Diabetes Association (2009) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 32: S62-S67 [CrossRef] [Google Scholar] [PubMed]
  44. Incani M, Sentinelli F, Perra L, Pani MG, Porcu M, et al. (2015) Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization. J Diabetes Invest 6: 44-50 [CrossRef] [Google Scholar] [PubMed]
  45. Hu Y, Liu W, Chen Y, Zhang M, Wang L, et al. (2010) Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 47: 231-236 [CrossRef] [Google Scholar] [PubMed]
  46. Mayega RW, Guwatudde D, MakumbiFE, Nakwagala FN, Peterson S, et al. (2014) Comparison of fasting plasma glucose and haemoglobin A1c pointof- care tests in screening for diabetes and abnormal glucose regulation in a rural low income setting. Diabetes Research Clinical Practice 104: 112-120 [CrossRef] [Google Scholar] [PubMed]
  47. Wang J, Zhang RY, Chen RP, Sun J, Yang R, et al. (2013) Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population. BMC Public Health 13: 633 [CrossRef] [Google Scholar] [PubMed]
  48. Di Mascio P, Kaiser S, SiesH (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274: 532-538 [CrossRef] [Google Scholar] [PubMed]
  49. Palozza P, Simone R, Catalano A, Boninsegna A, Böhm V, et al. (2010) Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. J Nutr Biochem 21: 34-46 [CrossRef] [Google Scholar] [PubMed]
  50. Ried K, Fakler P (2011) Protective effect of lycopene on serum cholesterol and blood pressure: Meta-analyses of intervention trials. Maturitas 68: 299- 310 [CrossRef] [Google Scholar] [PubMed]
  51. Krutovskikh V, Asamoto M, Takasuka N, Murakoshi M, Nishino H, et al. (1997) Differential dose-dependent effects of alpha-, beta-carotenes and lycopene on gap junctional intercellular communication in rat liver in vivo. Jpn J Cancer Res 88: 1121-1124 [CrossRef] [Google Scholar] [PubMed]
  52. Leone A, Longo C, Trosko JE (2012) The chemopreventive role of dietary phytochemicals through gap junctional intercellular communication. Phytochem Rev 11: 285-307 [Google Scholar]
  53. Ford ES, Will JC, Bowman BA, Venkat Narayan KM (1999) Diabetes mellitus and serum carotenoids: Findings from the Third national health and nutrition examination survey. Am J Epidemiol 149: 168-176 [CrossRef] [Google Scholar] [PubMed]
  54. Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, et al. (1996) Cis-trans lycopene isomers,carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5: 823-833 [Google Scholar] [PubMed]
  55. Hadley CW, Clinton SK, Schwartz SJ (2008) The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. Am J Clin Nutr 133: 727-732 [CrossRef] [Google Scholar] [PubMed]
  56. Stahl W, Sies H (1992) Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr 122: 2161-2166 [CrossRef] [Google Scholar] [PubMed]
  57. Erdman JW (2005) How do nutritional and hormonal status modify the bioavailability, uptake, and distribution of different isomersof lycopene? J Nutr 135: 2046S-2047S [CrossRef] [Google Scholar] [PubMed]
  58. Britton G (1995) Structure and properties of carotenoids in relation to function. FASEB J 9: 1551- 1558 [CrossRef] [Google Scholar] [PubMed]
  59. Boileau AC, Merchen NR, WassonK, Atkinson CA, Erdman JW, et al. (1999) Cis-lycopene is more bioavailable than Trans-lycopene in vitro and in vivo in lymph-cannulatedferre. J Nutr 129: 1176-1181 [CrossRef] [Google Scholar] [PubMed]
  60. Porrini 55- Riso P, Brusamolino A, Berti C, Guarnieri S, Visioli F, et al. (2005) Daily intake of a formulated tomato drink affects carotenoid plasma and lymphocyte concentrations and improves cellular antioxidant protection. Br J Nutr 93: 93-99 [CrossRef] [Google Scholar] [PubMed]
  61. Thurnham DI, Flora PS (1988) Do higher vitamin A requirements in men explain the difference between the sexes in plasma provitamin A carotenoids and retinol. Proc Nutr Soc 47: 181A
  62. Sugiura M, Mieko Nakamura M, Ogawa K, Ikoma Y, Yano M, et al. (2015) High-serum carotenoids associated with lower risk for developing type 2 diabetes among Japanese subjects: Mikkabi cohort study. BMJ Open Diabetes Res Care 3: 000147 [CrossRef] [Google Scholar] [PubMed]
  63. Unlu NZ, Bohn T, Francis DM, Nagaraja HN, Clinton SK, et al. (2007) Lycopene from heat-induced cis-isomer-rich tomato sauce is more bioavailable than from all-trans-rich tomato sauce in human subjects. Br J Nutr 98: 140-146 [CrossRef] [Google Scholar] [PubMed]
  64. Alda LM, GogoaşăI, Bordean DM, Gergen I, Alda S, et al. (2009) Lycopene content of tomatoes and tomato products. JAP & T 15: 540-542 [CrossRef] [Google Scholar]
  65. Forman MR, Borkowf CB, Cantwell MM, Steck S, Schatzkin A, et al. (2009) Components of variation in serum carotenoid concentrations: the Polyp prevention trial. Europ J Clin Nutr 63: 763–770 [CrossRef] [Google Scholar] [PubMed]
  66. Yong LC, Forman MR, Beecher GR, Graubard BI, Campbell WS, et al. (1994) Relationship between dietary intake and plasma concentrations of carotenoids in premenopausal women: application of the USDA-NCI carotenoid food-composition database. AAm J ClinNutr 60: 223-230 [CrossRef] [Google Scholar] [PubMed]
  67. Kohlmeier L, Kark JD, Gomez-Gracia E, Martin BC, Steck SE et al. (1997) Lycopene and myocardial infarction risk in the EURAMIC study. Am J Epidemiol 146: 618-626 [CrossRef] [Google Scholar] [PubMed]
  68. Shidfar F, Froghifar N, Vafa M, Rajab A, Hosseini S, et al. (2011) The effects of tomato consumption on serum glucose, apolipoprotein B, apolipoprotein A-I, homocysteine and blood pressure in type 2 diabetic patients. Int J Food Sci Nutr 62: 289-294 [CrossRef] [Google Scholar] [PubMed]
  69. Itsiopoulos C, Brazionis L, Kaimakamis M, Cameron M, Best JD, et al. (2011) Can the Mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study. Nutr Metab Cardiovasc Dis. 21: 740- 747 [CrossRef] [Google Scholar] [PubMed]
  70. Riso P, Visioli F, Erba D, Testolin G, Porrini M, et al. (2004) Lycopene and vitamin C concentrations increase in plasma and lymphocytes after tomato intake. Effects on cellular antioxidant protection. Eur J ClinNutr 58: 1350- 1358 [CrossRef] [Google Scholar] [PubMed]
  71. Frohlich K, Kauffmann K, Bitsch R, Bohm V (2006) Effects of ingestion of tomatoes, tomato juice and tomato puree on contents of lycopene isomers, tocopherols and ascorbic acid in human plasma as well as on lycopene isomer pattern. Br J Nutr 95: 734-741 [CrossRef] [Google Scholar] [PubMed]
  72. Subhash K, Bose C, Agrawal BK (2007) Effect of short term supplementation of tomatoes on antioxidant enzymes and lipid peroxidation in type-II diabetes. Indian J Clin Biochem 22: 95-98 [CrossRef] [Google Scholar] [PubMed]
  73. Upritchard JE, Sutherland WH, Mann JI (2000) Effect of supplementation with tomato juice, vitamin E and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 23: 733-738 [CrossRef] [Google Scholar] [PubMed]
  74. Cheng HM, Koutsidis G, Lodge JK, Ashor A, Siervo M, et al. (2017) Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis. Atherosclerosis 257: 100-108 [CrossRef] [Google Scholar] [PubMed]
  75. Burton-Freeman B, Sesso HD (2014) Whole food versus supplement: comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors. AdvNutr 5: 457-485 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.